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ylhydrazine  recovered  within  10  days  from  hemolytic  anemia 
(Figure 1), during which red blood cell numbers and hemato-
crit and reticulocyte levels were corrected (data not shown) and 
















































Parameters	 WT	 Foxo3–/–	 P
rbc (× 106/μl) 9.89 ± 0.49 8.87 ± 0.16 0.04
Hgb (g/dl) 14.88 ± 0.79 14.32 ± 0.76 0.31
Hct (%) 45.52 ± 2.20 46.69 ± 0.86 0.32
MCH (pg) 14.25 ± 0.10 15.82 ± 0.17 1.03 × 10–8
MCHC (g/dl) 30.21 ± 0.50 30.61 ± 0.39 0.27
MCV (fL) 47.34 ± 0.73 52.00 ± 0.72 8.59 × 10–5
RDW (%) 14.45 ± 0.05 16.19 ± 0.19 3.71 × 10–6
Results for WT (n = 10) and Foxo3–/– (n = 21) are shown as mean ± SEM. 
Hgb, hemoglobin; Hct, hematocrit; MCH, mean corpuscular hemoglobin; 
MCHC, MCH concentration; MCV, mean corpuscular volume; RDW, red 
cell distribution width. 
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Foxo3 is highly expressed in hematopoietic organs and is activated dur-































High oxidative stress in Foxo3–/– erythrocytes. (A) Kaplan Meier survival curve of wild-type and Foxo3–/– mice (n = 6 in each group) treated with a single 
dose of intraperitoneal injection of phenylhydrazine (PHZ; 100 mg/kg). P < 0.0001, log-rank test; 1 of 2 independent experiments is shown. (B) ROS 
measurement in WT and Foxo3–/– erythrocytes (note absence of any exogenously added peroxide). (C) Histogram of results from B (mean ± SEM, n = 6; 
**P < 0.02). (D) Protein oxidation in erythrocytes. DNPH, 2,4-dinitrophenylhydrazine. (E) Quantitative analysis of the oxidative status of WT (n = 3) and 
Foxo3–/– (n = 4) erythrocytes by comparison of signal intensity of lanes in D using BandScan software version 4.5 (Glyco). *P < 0.05, Student’s t test.
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The  activity  of  endogenous  Foxo3,  using  luciferase  report-
er containing 5  tandem repeat FoxO binding sites, was shown 
to  be  significantly  upregulated  more  than  8-fold  during  36 
hours  of  ex  vivo  maturation  of  both  early  erythroid  precur-
sors  (mostly  CD71+TER119–  proerythroblasts,  which  became 

















Reduced erythrocyte lifespan in Foxo3–/– mice. (A) Erythrocyte lifespan 
was measured by in vivo biotin labeling. At day 0, 95% of erythrocytes 
were labeled. Animals were bled every 5 days, and the surviving labeled 
cells were analyzed by flow cytometry. (B) Reticulocyte index was 
measured in Foxo3–/– and WT mice. Results represent mean ± SEM; 
n = 6 in each group. *P < 0.05, **P < 0.01, Student’s t test.
Figure 3
ROS induced shortened erythrocyte lifespan in Foxo3–/– mice. (A) In 
vivo NAC therapy improves the lifespan of erythrocytes in Foxo3–/– 
mice. WT and Foxo3–/– mice were treated intraperitoneally with NAC 
(100 mg/kg) or PBS 3 times a week; after 3 weeks, erythrocytes were 
biotinylated in vivo and erythrocyte lifespan measured as in Figure 2, 
while NAC (or PBS) treatment continued for another 3 weeks. (B) 
Reticulocyte index was measured after 6 weeks in all mice. One of 2 
independent experiments is shown. Results represent mean ± SEM, 
n = 6 per group; *P < 0.05.
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Foxo3 expression is upregulated during erythroblast maturation. (A) QRT-PCR analysis of Foxo1, Foxo3, and Foxo4 in embryonic and adult hema-
topoietic organs. Shown are representative results from 3 independent experiments performed in duplicate. (B) Western blot analysis of endogenous 
FoxO protein expression in the bone marrow. Protein lysates of HEK293T cells overexpressing FOXO1, FOXO3a, and FOXO4 cDNAs were used as 
positive controls. (C) QRT-PCR analysis of indicated transcripts from subpopulations of fetal liver isolated by flow cytometry according to their CD71 
and TER119 expression. Note that expression of Foxo3 is the highest in the most mature erythroid cell subpopulation (CD71–TER119+). Representa-
tive results from 3 independent experiments performed in triplicate are shown as mean ± SEM. Cells differentiate from a double CD71–TER119– cell 
subpopulation enriched in hematopoietic progenitors, including erythroid progenitors, to CD71+TER119– cells containing mostly proerythroblasts 
and basophilic erythroblasts, then to CD71+TER119+ cells enriched for basophilic/polychromatophilic erythroblasts, and finally to CD71–TER119+ 
cells consisting mostly of normoblasts. (D) Western blot analysis of Foxo3 in subpopulations of fetal liver enriched for progenitors (TER119–) and for 
erythroid precursors (TER119+, erythroblasts) using anti-FOXO3a antibody. Anti–GATA-1 (N6) and anti–β-actin antibodies were used as controls.
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Foxo3 translocates to the nucleus and regulates 
transcription of anti-oxidant enzymes in primary 
fetal liver erythroblasts. (A) Immunofluorescence 
staining of Foxo3 (red) in freshly isolated E14.5 
fetal liver erythroid subpopulations using anti-
FOXO3a antibody was performed and samples 
were counterstained with nuclear DAPI (blue). 
(B) Quantification of nuclear Foxo3 in CD71–
TER119– cells as compared with CD71–TER119+ 
cells. Data were analyzed from an average of 50 
cells from each subpopulation in A. (C) Foxo3 
expression was investigated in nucleated, deep 
red fluorescing agent (DRAQ5) positive cells. 
DRAQ5+CD71–TER119– and DRAQ5+CD71–
TER119+ cells were FACS sorted from E14.5 
fetal liver and subjected to immunofluorescence 
staining using anti-FOXO3a antibody (green). 
(D) Quantification of results from C is shown 
for at least 50 cells from each subpopulation as 
mean ± SEM. ***P < 0.001, Student’s t test. (E) 
FACS-sorted erythroid precursor subpopula-
tions CD71+TER119– and CD71+TER119+ cells 
were transfected with synthetic reporter contain-
ing 5 tandem repeat FoxO binding site (pTA-
FoxO5BS-Luc) or mutant (pTA-FoxO5BSmut-
Luc) (top panel), or a catalase luciferase reporter 
containing 2 FoxO binding sites (pTA-cata.
mut-Luc) or mutant (pTA-catalase-Luc) (bottom 
panel), then cultured as previously described 
in the presence of Epo (2 U/ml) (28, 39), and 
luciferase activity was analyzed after 36 hours. 
EKLF reporter (pEKLF-Luc) (56) was used as a 
positive control. Data representative of normal-
ized results from at least 4 independent experi-
ments performed in triplicate are shown as mean 
± SEM. **P < 0.01; †P < 0.002; #P < 0.0001. (F) 
Transcriptional activity of Foxo3 during matura-
tion of fetal liver erythroid precursors. TER119– 
fetal liver cells (enriched in progenitors) were 
transiently transfected with an empty luciferase 
reporter (pGL-3) or a SOD2 luciferase reporter 
containing 2 FoxO binding sites (pSod-Luc) or 
its mutant (pSOD-DBE12mut-Luc) and cultured 
as described above, and luciferase activity was 
determined at 24 and 48 hours. Results are 
shown as mean ± SEM; n = 4 for each group.
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tor,  p21CIP1/WAF1/Sdi1  (Cdkn1a),  which,  similar  to  p27KIP1,  is  an 
inhibitor  of  the  transition  from  the  G1  to  the  S  phase  of  cell 
cycle  and  a  known  downstream  target  of  Foxo3  (41),  was  sig-
nificantly  upregulated  in  Foxo3-deficient  cells  (Figure  7A). 
p21CIP1/WAF1/Sdi1  expression 
is  induced  in  response  to 
oxidative stress (42), either 
as part of a transcription-
al  program  activated  by 
p53  tumor  suppressor  in 
response to cellular stress 
(43)  or  induced  indepen-
dently  of  p53  (44).  Thus 
the  status  of  p53  was 
investigated. In agreement 


















































Mitotic arrest in Foxo3–/– erythroid precursor cells. (A) Left: Flow cytometry analysis of live WT and Foxo3–/– bone 
marrow erythroid precursors according to their expression of CD71 and TER119. Gates I to IV depict erythroid cell 
populations with an increasing degree of maturation. Numbers by gates represent percentage of distribution of cells 
within that gate. Note decrease of Foxo3–/– mature erythroid cells (gate IV) and increase of Foxo3–/– precursors in gate 
II as compared with WT (representative flow cytometry analysis of 9 experiments is shown). Right: Representative 
analysis of cell cycle distribution in CD71+TER119+ cells (gate II) from 6 independent experiments. (B) Ratio of gate 
IV to gate II from A (n = 9, mean ± SEM; **P < 0.01, Student’s t test). (C) Cell cycle analysis of cells in gate II from left 
panel of A (n = 6, mean ± SEM; ***P < 0.001, Student’s t test) is shown. WT and Foxo3-deficient CD71+TER119+ (gate 
II) bone marrow erythroid cells were FACS sorted and analyzed for cell cycle distribution using Hoechst (A, right panel, 
and C). Percentage of cells in G1, S, and G2/M phases of cell cycle are shown (n = 6, mean ± SEM; ***P < 0.001, 
Student’s t test). No significant difference was found in the analysis of cell cycle of other subpopulations.
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State of oxidative stress in Foxo3-deficient erythroblasts. (A) QRT-PCR analysis of cell cycle regulator genes in freshly isolated FACS-sorted 
erythroblasts at an intermediary (CD71+TER119+) stage of differentiation from wild-type and Foxo3-deficient bone marrow cells. Note upregulation 
of p21CIP1/WAF1/Sdi1 in intermediary erythroblasts (CD71+TER119+ cells are the same as those shown in gate II of Figure 6A). (B) Left: QRT-PCR 
analysis of p53 expression in the same cells as in A. Right: p53 reporter luciferase activity in WT and Foxo3-deficient bone marrow TER119– cells 
36 hours after transfection and in vitro culture as in Figure 5, E and F. Representative of 2 independent experiments. (C) QRT-PCR analysis of 
antioxidant genes in the same populations as in A. Note upregulation of p53 downstream antioxidant targets GADD45 and SESN2. Representa-
tive of 4 independent experiments performed in duplicate or more. *P < 0.05, Student’s t test.
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that  is  known  to  be  activated  in  response  to  stress  (50,  51) 









































ROS-induced upregulation of p21CIP1/WAF1/Sdi1. TER119– bone marrow 
cells were cultured with or without 100 μM NAC, and the expression of 
p21CIP1/WAF1/Sdi1 was measured by QRT-PCR after 36 hours. *P < 0.05 
Student’s t test.
Figure 9
Foxo3 is required for expression of antioxidant enzymes. QRT-
PCR analysis of antioxidant enzymes in bone marrow erythroblasts 
(TER119+) cells. GPX1, glutathione peroxidase 1. n = 3; *P < 0.05, 
**P < 0.02, Student’s t test.
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roblast response to phenylhy-
drazine in Foxo3–/– mice. WT 
and Foxo3-deficient mice were 
treated with phenylhydrazine 
(100 mg/kg) or PBS and sac-
rificed 24 hours later. (A) Flow 
cytometry analysis of relative 
frequency of mature eryth-
roblasts in the bone marrow, 
spleen, and blood, calculated by 
the ratio of mature erythroblasts 
(CD71–TER119+) to total eryth-
roblasts (CD71+TER119+ and 
CD71–TER119+). n = 3 in each 
group; *P < 0.05, Student’s t 
test. (B) Measurement of ROS 
concentration in erythroblasts 
(TER119+ cells). #P < 0.01; 
**P < 0.001.
Figure 11
Model of the regulation of Foxo3 subcellular localization in erythro-
poiesis. Inhibition of EpoR signaling, which includes inhibition of the 
PI3-kinase/AKT pathway, as a result of downregulation of EpoR on 
erythroblasts, coupled with accumulation of hemoglobin, may result in 
ROS signaling, leading to Foxo3 nuclear localization and activation.
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using  1%  Triton  X-100,  3%  BSA,  and  1×  PBS,  incubated  with  anti-
FOXO3a antibody (1:500) in 1% BSA for 1 hour, washed and stained 
with Alexa Fluor 594–conjugated anti-rabbit IgG antibody (5 μg/ml; 













siently  transfected  with  50  ng  of  pRL-TK  (Promega)  alone  or  with 
pRL-TK and 2 μg of one of the following: catalase luciferase report-
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FOXO  signaling  pathway  mediates  oxidative-





























mediate  suppression  of  TRAIL-induced  apop-
tosis  through  inhibition  of  forkhead  FOXO3a 
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